The kinetics of gap junction currents are sensitive to the ionic composition of the pipette solution.
Myocytes were isolated from neonatal rat hearts using an enzymatic procedure. Cell pairs were used to control the junctional voltage, V(j), and to measure the transjunctional current, I(j), using the dual voltage-clamp method. V(j) gradients provoked I(j) signals with voltage-dependent inactivation. During voltage pulses, I(j) remained virtually constant at ¿V(j)¿ <40 mV. At ¿V(j)¿>40 mV, it inactivated with time to a residual level. The inactivation followed a single exponential. The time constant of I(j) inactivation, taui, and the size of I(j) at steady state, I(j,ss), were both sensitive to the ions in the pipette solution. I(j,ss) was smaller in the presence of tetraethylammonium aspartate (TEA+ aspartate-) than KC1, while taui was smaller in the presence of KC1 than TEA+ aspartate-. The modification of I(j,ss) is readily explained by a change in the residual conductance of the gap junction channels, gammaj,residual x The alterations in taui are correlated with a change in beta, the rate constant that describes the transition of the channel from the main state to the residual state. Pipette solutions may affect the kinetics of gap junction currents by altering the conductive and/or kinetic parameters. Computer simulations revealed a substantial influence of the latter, but only a marginal effect of the former. Conceivably, ions of the pipette solution may affect the kinetics of gap junction channels by screening surface charges of the channel wall.
Valiunas
V
V
Department of Physiology, University of Bern, Switzerland.
Vogel
R
R
Weingart
R
R
D000818:Animals; D000831:Animals, Newborn; D001224:Aspartic Acid / Q000494:pharmacology; D003198:Computer Simulation; D018031:Connexin 43 / Q000502:physiology; D004553:Electric Conductivity; D017629:Gap Junctions / Q000502:physiology*; D007473:Ion Channels / Q000502:physiology*; D007700:Kinetics; D009206:Myocardium / Q000648:ultrastructure; D018408:Patch-Clamp Techniques; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D012996:Solutions; D019789:Tetraethylammonium / Q000494:pharmacology
D018031:Connexin 43; D007473:Ion Channels; D012996:Solutions; D001224:Aspartic Acid; D019789:Tetraethylammonium; D011189:Potassium Chloride